Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.38)
# 2,559
Out of 5,148 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $49 → $47 | $48.83 | -3.56% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $118.17 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $189.02 | +307.36% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $39.81 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $81.37 | -16.43% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $14.31 | +361.22% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $132.89 | +116.72% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $508.58 | -48.88% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $307.23 | -31.32% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $5.01 | +977.84% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $200.17 | -79.52% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $279.59 | +19.82% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $267.56 | +25.21% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $49 → $47
Current: $48.83
Upside: -3.56%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $118.17
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $189.02
Upside: +307.36%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $39.81
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $81.37
Upside: -16.43%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $14.31
Upside: +361.22%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $132.89
Upside: +116.72%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $508.58
Upside: -48.88%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $307.23
Upside: -31.32%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $5.01
Upside: +977.84%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $200.17
Upside: -79.52%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $279.59
Upside: +19.82%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $267.56
Upside: +25.21%